Related Experiment Video
Updated: Jun 4, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Solid phase synthesis of globomycin and SF-1902 A5
Francisco Sarabia1, Samy Chammaa, Cristina García-Ruiz
1Department of Organic Chemistry, Faculty of Sciences, University of Malaga, Campus de Teatinos s/n 29071, Malaga, Spain. frsarabia@uma.es
Researchers synthesized globomycin and SF-1902 A(5) antibiotics using solid-phase technology and new epoxidation methods. This approach enables rapid analog generation for novel signal peptidase II inhibitors.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Antibiotic Discovery
Background:
- Globomycin and SF-1902 A(5) are natural lipocyclodepsipeptide antibiotics.
- These compounds target the enzyme signal peptidase II, crucial for bacterial processes.
- Developing efficient synthetic routes is key to exploring their therapeutic potential.
Purpose of the Study:
- To report the total syntheses of globomycin and SF-1902 A(5).
- To develop a versatile synthetic platform for generating antibiotic analogs.
- To facilitate the discovery of new signal peptidase II inhibitors.
Main Methods:
- Solid-phase peptide synthesis for the peptidic fragment.
- Asymmetric epoxidation methodology for the lipidic chain construction.
- Solid-phase fragment coupling and macrolactonization for final assembly.
Main Results:
- Successful synthesis of globomycin and SF-1902 A(5).
- Demonstrated feasibility of solid-phase fragment linkage and macrolactonization.
- Established a platform for rapid analog library generation.
Conclusions:
- The developed synthetic strategy provides efficient access to globomycin and SF-1902 A(5).
- The methodology allows for facile structural modifications, aiding in the search for novel antibiotics.
- This work supports the development of new signal peptidase II inhibitors for therapeutic applications.
More Related Videos
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
07:14Fabrication of a Biomimetic Nano-Matrix with Janus Base Nanotubes and Fibronectin for Stem Cell Adhesion
Published on: May 10, 2020